Quantbot Technologies LP Neurocrine Biosciences Inc Transaction History

Quantbot Technologies LP

$3.24 Billion
Q3 2025

A detailed history of Quantbot Technologies LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quantbot Technologies LP holds 3,861 shares of NBIX stock, worth $559,304. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,861

Previous 6,006 35.71%

Holding current value

$559,304

Previous $754,000 28.12%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$123.98 - $146.67 $265,937 - $314,607	-2,145 Reduced 35.71%	3,861 $542,000
Q2 2025 Aug 13, 2025	BUY	$87.54 - $128.18 $525,765 - $769,849	6,006 New	6,006 $754,000
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $88,112 - $117,772	769 New	769 $88,000
Q1 2024 May 06, 2024	SELL	$130.4 - $143.74 $217,116 - $239,327	-1,665 Reduced 98.46%	26 $3,000
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $57,065 - $71,424	-538 Reduced 24.14%	1,691 $222,000

Q3 2023 Nov 07, 2023	BUY	$94.02 - $117.1 $148,645 - $185,135	1,581 Added 243.98%	2,229 $250,000
Q2 2023 Aug 08, 2023	BUY	$89.53 - $104.87 $4,655 - $5,453	52 Added 8.72%	648 $61,000
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $285,059 - $372,627	-3,029 Reduced 83.56%	596 $60,000
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $386,860 - $460,592	3,625 New	3,625 $432,000
Q2 2022 Aug 09, 2022	BUY	$75.79 - $100.07 $106,939 - $141,198	1,411 New	1,411 $137,000
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $249,735 - $326,810	-3,447 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $234,409 - $312,605	2,943 Added 583.93%	3,447 $293,000
Q3 2021 Nov 09, 2021	BUY	$86.18 - $99.03 $43,434 - $49,911	504 New	504 $48,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $9,194 - $12,537	-105 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $491,389 - $612,497	-5,654 Reduced 98.18%	105 $10,000
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $440,412 - $618,987	4,580 Added 388.46%	5,759 $553,000
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $91,812 - $140,658	1,079 Added 1079.0%	1,179 $143,000
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $450,434 - $682,218	-5,997 Reduced 98.36%	100 $8,000
Q4 2019 Feb 10, 2020	BUY	$86.8 - $118.57 $282,794 - $386,301	3,258 Added 114.76%	6,097 $655,000
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $53,560 - $64,858	639 Added 29.05%	2,839 $255,000
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $116,523 - $147,218	-1,613 Reduced 42.3%	2,200 $185,000
Q1 2019 May 13, 2019	BUY	$69.31 - $91.53 $224,217 - $296,099	3,235 Added 559.69%	3,813 $335,000
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $92,163 - $167,761	-1,349 Reduced 70.01%	578 $41,000
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $190,541 - $242,512	1,927 New	1,927 $236,000

Others Institutions Holding NBIX

# of Institutions

726

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Neurocrine Biosciences Inc Transaction History